[Increased effect of phenprocoumon (Marcumar) in nephrotic syndrome].
D015110:4-Hydroxycoumarins / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000378:metabolism*; D010644:Phenprocoumon / Q000378:metabolism / Q000627:therapeutic use*; D011485:Protein Binding; D011655:Pulmonary Embolism / Q000188:drug therapy*; D012709:Serum Albumin / Q000172:deficiency
D015110:4-Hydroxycoumarins; D012709:Serum Albumin; D010644:Phenprocoumon
Erhöhte Wirkung von Phenprocoumon (Marcumar) bei nephrotischem Syndrom.